50 per cent reduction in death rate of prostate cancer
There are 50 per cent chances of death risks associated with prostate cancer with a new treatment.
The way androgen deprivation therapy or the NADT leads to changes in treating the disease, patients can have a new hope because the therapy itself is not new.
People who have reached advanced stage of the disease are put on this therapy but according to the new findings, many cases can be cured with giving the therapy just six months of the treatment.
Every year about 37,000 new cases of prostate cancer are diagnosed even today. The therapy helps in decreasing the levels of male hormones that are behind causing prostate cancer.
There are little side effects and the treatment can work for up to 10 years.
Chris Parker, of the Royal Marsden cancer hospital in west London said, “This is an important trial and has two clear messages for current clinical practice. First, it confirms that NADT significantly reduces mortality after radiotherapy for high-risk prostate cancer, and is a standard of care and it helps to resolve the uncertainty regarding NADT duration.”
New Zealand News
- Tesla Model Y Performance becomes little bit more expensive to order in China
- Porsche’s recently unveiled Mission R Concept previews electric race cars of future
- Chinese manufacturer GAC’s Aion V e-SUV can charge 0-80% in just 8 minutes
- Oshidori International exits Japanese casino race, citing serious ethical irregularities
- CATL and LG Energy account for nearly 54% of global xEV battery market: SNE Research
- Italian motorcycle racer Valentino Rossi enters e-bike business with VR46 MTB range
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain
- TenneT adds more electric BMWs to study use of EVs to support power grids
- Italy’s ASPI announces plans to install cross-country ultra-fast EV charging network